These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16508364)

  • 21. Effect of allopurinol, superoxide-dismutase, and hyperbaric oxygen on flap survival.
    Prada FS; Arrunategui G; Alves MC; Ferreira MC; Zumiotti AV
    Microsurgery; 2002; 22(8):352-60. PubMed ID: 12497572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of botulinum toxin A on skin flap survival in rats.
    Kim YS; Roh TS; Lee WJ; Yoo WM; Tark KC
    Wound Repair Regen; 2009; 17(3):411-7. PubMed ID: 19660050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial.
    Mehta SR; Granger CB; Eikelboom JW; Bassand JP; Wallentin L; Faxon DP; Peters RJ; Budaj A; Afzal R; Chrolavicius S; Fox KA; Yusuf S
    J Am Coll Cardiol; 2007 Oct; 50(18):1742-51. PubMed ID: 17964037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of low-molecular-weight heparin in the survival of a rabbit congested skin flap.
    Miyawaki T; Jackson IT; Elmazar H; Bier UC; Barakat K; Andrus L; Williams F
    Plast Reconstr Surg; 2002 May; 109(6):1994-9. PubMed ID: 11994604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant leptin administration improves early angiogenesis in full-thickness skin flaps: an experimental study.
    Liapakis IE; Anagnostoulis S; Karayiannakis AJ; Korkolis DP; Lambropoulou M; Arnaud E; Simopoulos CE
    In Vivo; 2008; 22(2):247-52. PubMed ID: 18468410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of calcitonin gene-related peptide on tissue survival, blood flow and neutrophil recruitment in experimental skin flaps.
    Jansen GB; Törkvist L; Löfgren O; Raud J; Lundeberg T
    Br J Plast Surg; 1999 Jun; 52(4):299-303. PubMed ID: 10624298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enoxaparin and fondaparinux attenuates endothelial damage in endotoxemic rats.
    Iba T; Okamoto K; Ohike T; Tajirika T; Aihara K; Watanabe S; Kayhanian H
    J Trauma Acute Care Surg; 2012 Jan; 72(1):177-82. PubMed ID: 22310127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The reduced anticoagulant effect of fondaparinux at low antithrombin levels.
    Dempfle CE; Eichner J; Suvajac N; Ahmad-Nejad P; Neumaier M; Borggrefe M
    Anesth Analg; 2009 Sep; 109(3):712-6. PubMed ID: 19690236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of nitric oxide synthase inhibition on blood flow and survival in experimental skin flaps.
    Gribbe O; Samuelson UE; Wiklund NP
    J Plast Reconstr Aesthet Surg; 2007; 60(3):287-93. PubMed ID: 17293287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute and sustained effects of vascular endothelial growth factor on survival of flaps and skin grafts.
    Zhang F; Lineaweaver W
    Ann Plast Surg; 2011 May; 66(5):581-2. PubMed ID: 21451385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the effect of sildenafil and vascular endothelium growth factor combination treatment on skin flap survival in rats.
    Tsai JW; Ayubi FS; Hart KL; Baur DA; Parham MA; Moon JK; Vazquez R; Chasen AB; Zhang Z; Pizarro JM
    Aesthetic Plast Surg; 2008 Jul; 32(4):624-31. PubMed ID: 18443849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of fondaparinux in patients with acute coronary syndromes.
    Bassand JP; Richard-Lordereau I; Cadroy Y
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1013-26. PubMed ID: 18035917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Thrombolytic, Anticoagulant, and Vasodilator Agents on the Survival of Random Pattern Skin Flap.
    Aral M; Tuncer S; Şencan A; Elmas Ç; Ayhan S
    J Reconstr Microsurg; 2015 Sep; 31(7):487-92. PubMed ID: 26212388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
    Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
    Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk.
    Joyner CD; Peters RJ; Afzal R; Chrolavicius S; Mehta SR; Fox KA; Granger CB; Franzosi MG; Flather M; Budaj A; Bassand JP; Yusuf S
    Am Heart J; 2009 Mar; 157(3):502-8. PubMed ID: 19249421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effectiveness of gene therapy with vascular endothelial growth factor or shock wave therapy to reduce ischaemic necrosis in an epigastric skin flap model in rats.
    Meirer R; Huemer GM; Oehlbauer M; Wanner S; Piza-Katzer H; Kamelger FS
    J Plast Reconstr Aesthet Surg; 2007; 60(3):266-71. PubMed ID: 17293284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
    Mehta SR; Boden WE; Eikelboom JW; Flather M; Steg PG; Avezum A; Afzal R; Piegas LS; Faxon DP; Widimsky P; Budaj A; Chrolavicius S; Rupprecht HJ; Jolly S; Granger CB; Fox KA; Bassand JP; Yusuf S;
    Circulation; 2008 Nov; 118(20):2038-46. PubMed ID: 18955665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose response of enoxaparin at the cremaster muscle flap microcirculation.
    Ertaş NM; Goldman C; Deitcher S; Siemionow M
    Microsurgery; 2005; 25(2):147-51. PubMed ID: 15704227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fondaparinux and enoxaparin in comparison to unfractionated heparin in preventing thrombus formation on mechanical heart valves in an ex vivo rabbit model.
    Schlitt A; Buerke M; Hauroeder B; Peetz D; Hundt F; Bickel C; Schaefer I; Meyer J; Rupprecht HJ
    Thromb Haemost; 2003 Aug; 90(2):245-51. PubMed ID: 12888871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.